Details for New Drug Application (NDA): 020155
✉ Email this page to a colleague
NDA 020155 describes VIDEX, which is a drug marketed by Bristol and Bristol Myers Squibb and is included in four NDAs. Additional details are available on the VIDEX profile page.
The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for 020155
| Tradename: | VIDEX |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | didanosine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020155
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 100MG/PACKET | ||||
| Approval Date: | Oct 9, 1991 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 167MG/PACKET | ||||
| Approval Date: | Oct 9, 1991 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 250MG/PACKET | ||||
| Approval Date: | Oct 9, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
